These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12604879)

  • 1. Ventricular tachyarrhythmias in a canine model of LQT3: arrhythmogenic effects of sympathetic activity and therapeutic effects of mexiletine.
    Chinushi M; Tagawa M; Sugiura H; Komura S; Hosaka Y; Washizuka T; Aizawa Y
    Circ J; 2003 Mar; 67(3):263-8. PubMed ID: 12604879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenesis of T wave alternans associated with surface QRS complex alternans and the role of ventricular prematurity: observations from a canine model of LQT3 syndrome.
    Chinushi M; Hosaka Y; Washizuka T; Furushima H; Aizawa Y
    J Cardiovasc Electrophysiol; 2002 Jun; 13(6):599-604. PubMed ID: 12108505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggers of ventricular tachyarrhythmias and therapeutic effects of nicorandil in canine models of LQT2 and LQT3 syndromes.
    Chinushi M; Kasai H; Tagawa M; Washizuka T; Hosaka Y; Chinushi Y; Aizawa Y
    J Am Coll Cardiol; 2002 Aug; 40(3):555-62. PubMed ID: 12142125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long-QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization.
    Chinushi M; Restivo M; Caref EB; El-Sherif N
    Circ Res; 1998 Sep; 83(6):614-28. PubMed ID: 9742057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycle length-associated modulation of the regional dispersion of ventricular repolarization in a canine model of long QT syndrome.
    Chinushi M; Caref EB; Restivo M; Noll G; Aizawa Y; El-Sherif N
    Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1247-57. PubMed ID: 11523611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of arrhythmogenicity of the short-long cardiac sequence that precedes ventricular tachyarrhythmias in the long QT syndrome.
    El-Sherif N; Caref EB; Chinushi M; Restivo M
    J Am Coll Cardiol; 1999 Apr; 33(5):1415-23. PubMed ID: 10193747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous magnesium in a prolonged QT interval model of polymorphic ventricular tachycardia focus on transmural ventricular repolarization.
    Chinushi M; Sugiura H; Komura S; Hirono T; Izumi D; Tagawa M; Furushima H; Aizawa Y
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):844-50. PubMed ID: 16105013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
    Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
    J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of autonomic nervous activity in the antiarrhythmic effects of magnesium sulfate in a canine model of polymorphic ventricular tachyarrhythmia associated with prolonged QT interval.
    Chinushi M; Izumi D; Komura S; Ahara S; Satoh A; Furushima H; Washizuka T; Aizawa Y
    J Cardiovasc Pharmacol; 2006 Sep; 48(3):121-7. PubMed ID: 17031266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic vs. pro-arrhythmic effects depending on the intensity of adrenergic stimulation in a canine anthopleurin-A model of type-3 long QT syndrome.
    Chinushi M; Izumi D; Iijima K; Ahara S; Komura S; Furushima H; Hosaka Y; Aizawa Y
    Europace; 2008 Feb; 10(2):249-55. PubMed ID: 18256131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of discordant T wave alternans in the in vivo heart.
    Chinushi M; Kozhevnikov D; Caref EB; Restivo M; El-Sherif N
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):632-8. PubMed ID: 12875425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
    Frommeyer G; Garthmann J; Ellermann C; Dechering DG; Kochhäuser S; Reinke F; Köbe J; Wasmer K; Eckardt L
    Europace; 2018 Aug; 20(8):1375-1381. PubMed ID: 29016765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Am Coll Cardiol; 2000 Mar; 35(3):778-86. PubMed ID: 10716483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.
    Fabritz L; Kirchhof P; Franz MR; Nuyens D; Rossenbacker T; Ottenhof A; Haverkamp W; Breithardt G; Carmeliet E; Carmeliet P
    Cardiovasc Res; 2003 Mar; 57(4):1085-93. PubMed ID: 12650887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restitution properties and occurrence of ventricular arrhythmia in LQT2 type of long QT syndrome.
    Yamauchi S; Yamaki M; Watanabe T; Yuuki K; Kubota I; Tomoike H
    J Cardiovasc Electrophysiol; 2002 Sep; 13(9):910-4. PubMed ID: 12380931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
    Schwartz PJ; Priori SG; Locati EH; Napolitano C; Cantù F; Towbin JA; Keating MT; Hammoude H; Brown AM; Chen LS; Colatsky TJ
    Circulation; 1995 Dec; 92(12):3381-6. PubMed ID: 8521555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: potential utility of mexiletine for the treatment of drug-induced long QT syndrome.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn J Pharmacol; 2000 Aug; 83(4):327-34. PubMed ID: 11001179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic ventricular tachycardias induced by D-sotalol and phenylephrine in canine preparations of atrioventricular block: initiation in the conduction system followed by spatially unstable re-entry.
    Derakhchan K; Cardinal R; Brunet S; Klug D; Pharand C; Kuś T; Sasyniuk BI
    Cardiovasc Res; 1998 Jun; 38(3):617-30. PubMed ID: 9747430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.